Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoid Disease”

4,741 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,741 results

Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07218510
What this trial is testing

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Ended earlyNCT04973527
What this trial is testing

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 9
Not applicableLooking for participantsNCT05641961
What this trial is testing

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Who this might be right for
Childhood CancerHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 30
Testing effectiveness (Phase 2)Looking for participantsNCT05660473
What this trial is testing

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 100
Not applicableStudy completedNCT01843673
What this trial is testing

Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Virginia Commonwealth University 16
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Testing effectiveness (Phase 2)Ended earlyNCT01745913
What this trial is testing

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+2 more
Weill Medical College of Cornell University 2
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Not applicableStudy completedNCT04630015
What this trial is testing

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808610
What this trial is testing

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT02795182
What this trial is testing

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

Who this might be right for
LymphomaLeukemia
BeiGene 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT06673459
What this trial is testing

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Who this might be right for
T-Cell Lymphocytic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONTotal Body Irradiation+1 more
The First Affiliated Hospital of Soochow University 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Early research (Phase 1)Study completedNCT00868413
What this trial is testing

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie (prior sponsor, Abbott) 32
Testing effectiveness (Phase 2)Study completedNCT01466179
What this trial is testing

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 225
Post-approval studies (Phase 4)Active Not RecruitingNCT06918080
What this trial is testing

Hepatoprotective Measures for Children at High Risk of NAFLD

Who this might be right for
Non Alcoholic Fatty Liver Diseases (NAFLD)Obesity and OverweightAcute Lymphoblastic Leukemia
Ain Shams University 200
Early research (Phase 1)Study completedNCT00124189
What this trial is testing

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Who this might be right for
Chronic Lymphoproliferative Diseases
Geron Corporation 48
Very early researchUnknownNCT04156243
What this trial is testing

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

Who this might be right for
B Cell LymphomaB Cell Leukemia
iCell Gene Therapeutics 20
Load More Results